BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Company News  |  Deals

Bayer, Lead Discovery Center deal

Bayer's Bayer Schering Pharma AG subsidiary received exclusive, worldwide rights to IP covering an undisclosed preclinical kinase inhibitor from the center. Bayer will be...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >